83 FR 30947 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 127 (July 2, 2018)

Page Range		30947-30948
FR Document		2018-14143

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at http:// www.samhsa.gov/workplace.

Federal Register, Volume 83 Issue 127 (Monday, July 2, 2018)

[Federal Register Volume 83, Number 127 (Monday, July 2, 2018)]
[Notices]
[Pages 30947-30948]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-14143]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the internet at http://www.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace 
Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, 
Maryland 20857; 240-276-2600 (voice).

SUPPLEMENTARY INFORMATION: The Department of Health and Human Services 
(HHS) notifies federal agencies of the laboratories and Instrumented 
Initial Testing Facilities (IITF) currently certified to meet the 
standards of the Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were 
first published in the Federal Register on April 11, 1988 (53 FR 
11970), and subsequently revised in the Federal Register on June 9, 
1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 
(69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 
FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 
7920).
    The Mandatory Guidelines were initially developed in accordance 
with Executive Order 12564 and section 503 of Public Law 100-71. The 
``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' 
as amended in the revisions listed above, requires strict standards 
that laboratories and IITFs must meet in order to conduct drug and 
specimen validity tests on urine specimens for federal agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must 
have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), 
which attests that it has met minimum standards.
    In accordance with the Mandatory Guidelines dated January 23, 2017 
(82 FR 7920), the following HHS-certified laboratories and IITFs meet 
the minimum standards to conduct drug and specimen validity tests on 
urine specimens:

HHS-Certified Instrumented Initial Testing Facilities

Dynacare, 6628 50th Street NW, Edmonton, AB Canada T6B 2N7, 780-784-
1190 (Formerly: Gamma-Dynacare Medical Laboratories).

HHS-Certified Laboratories

ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 
844-486-9226.
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361-
8989/800-433-3823 (Formerly: Kroll Laboratory Specialists, Inc., 
Laboratory Specialists, Inc.).

[[Page 30948]]

Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 
804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., Scientific 
Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, 
Inc.).
Baptist Medical Center--Toxicology Laboratory, 11401 I-30, Little Rock, 
AR 72209-7056, 501-202-2783 (Formerly: Forensic Toxicology Laboratory 
Baptist Medical Center).
Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 
66215-2802, 800-445-6917.
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800-
235-4890.
Dynacare*, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679-
1630 (Formerly: Gamma-Dynacare Medical Laboratories).
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 
662-236-2609.
Laboratory Corporation of America Holdings, 7207 N. Gessner Road, 
Houston, TX 77040, 713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 
08869, 908-526-2400/800-437-4986 (Formerly: Roche Biomedical 
Laboratories, Inc.).
Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, 
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984 (Formerly: 
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, 
Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical 
Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche 
Group).
Laboratory Corporation of America Holdings, 1120 Main Street, 
Southaven, MS 38671, 866-827-8042/800-233-6339 (Formerly: LabCorp 
Occupational Testing Services, Inc.; MedExpress/National Laboratory 
Center).
LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 
66219, 913-888-3927/800-873-8845 (Formerly: Quest Diagnostics 
Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division 
of LabOne, Inc.).
MedTox Laboratories, Inc., 402 W County Road D, St. Paul, MN 55112, 
651-636-7466/800-832-3244.
Legacy Laboratory Services--MetroLab, 1225 NE 2nd Ave., Portland, OR 
97232, 503-413-5295/800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology 
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, 
Testing for Veterans Affairs (VA) Employees Only.
National Toxicology Laboratories, Inc., 1100 California Ave., 
Bakersfield, CA 93304, 661-322-4250/800-350-3515.
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, 
TX 77504, 888-747-3774 (Formerly: University of Texas Medical Branch, 
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory).
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 
91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology 
Laboratory).
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, 
WA 99204, 509-755-8991/800-541-7891x7.
Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635-
5840.
Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 
800-729-6432 (Formerly: SmithKline Beecham Clinical Laboratories; 
SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 
610-631-4600/877-642-2216 (Formerly: SmithKline Beecham Clinical 
Laboratories; SmithKline Bio-Science Laboratories).
Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 
95403, 800-255-2159.
STERLING Reference Laboratories, 2617 East L Street, Tacoma, WA 98421, 
800-442-0438.
U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., 
Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for 
Department of Defense (DoD) Employees Only.

    * The Standards Council of Canada (SCC) voted to end its Laboratory 
Accreditation Program for Substance Abuse (LAPSA) effective May 12, 
1998. Laboratories certified through that program were accredited to 
conduct forensic urine drug testing as required by U.S. Department of 
Transportation (DOT) regulations. As of that date, the certification of 
those accredited Canadian laboratories will continue under DOT 
authority. The responsibility for conducting quarterly performance 
testing plus periodic on-site inspections of those LAPSA-accredited 
laboratories was transferred to the U.S. HHS, with the HHS' NLCP 
contractor continuing to have an active role in the performance testing 
and laboratory inspection processes. Other Canadian laboratories 
wishing to be considered for the NLCP may apply directly to the NLCP 
contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 16, 
1996) as meeting the minimum standards of the Mandatory Guidelines 
published in the Federal Register on January 23, 2017 (82 FR 7920). 
After receiving DOT certification, the laboratory will be included in 
the monthly list of HHS-certified laboratories and participate in the 
NLCP certification maintenance program.

Charles P. LoDico,
Chemist.
[FR Doc. 2018-14143 Filed 6-29-18; 8:45 am]
 BILLING CODE 4160-20-P

Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices 30947

partnership with program originating programs and practices that have been Services (HHS) notifies federal agencies
Centers, providing oversight and reviewed by the Assistant Secretary for of the laboratories and Instrumented
management of agency quality Mental Health and Substance Use. Initial Testing Facilities (IITF) currently
improvement and performance certified to meet the standards of the
Delegation of Authority
management activities and for Mandatory Guidelines for Federal
advancing agency goals and objectives All delegations and re-delegations of Workplace Drug Testing Programs
related to program evaluation, authority made to SAMHSA officials (Mandatory Guidelines). The Mandatory
performance measurement, and quality that were in effect immediately prior to Guidelines were first published in the
improvement. Specifically, the Office: this reorganization, and that are Federal Register on April 11, 1988 (53
(1) Develops evaluation language for consistent with this reorganization, FR 11970), and subsequently revised in
Request for Proposals (RFPs), Request shall continue in effect pending further the Federal Register on June 9, 1994 (59
for Applications (RFAs), and other re-delegation. FR 29908); September 30, 1997 (62 FR
funding announcements to ensure a Dated: June 25, 2018. 51118); April 13, 2004 (69 FR 19644);
clear statement of evaluation Alex M. Azar II, November 25, 2008 (73 FR 71858);
expectations in the announcements; (2) Secretary. December 10, 2008 (73 FR 75122); April
develops and implements standard [FR Doc. 2018–14165 Filed 6–29–18; 8:45 am] 30, 2010 (75 FR 22809); and on January
measures for evaluating program BILLING CODE 4160–01–P
23, 2017 (82 FR 7920).
performance and improvement of The Mandatory Guidelines were
services; (3) manages the design of initially developed in accordance with
SAMHSA program evaluations in DEPARTMENT OF HEALTH AND Executive Order 12564 and section 503
collaboration with the relevant HUMAN SERVICES of Public Law 100–71. The ‘‘Mandatory
Center(s); (4) monitors evaluation Guidelines for Federal Workplace Drug
contracts to ensure implementation of Substance Abuse and Mental Health Testing Programs,’’ as amended in the
planned evaluation and provides early Services Administration revisions listed above, requires strict
feedback regarding program start-up for standards that laboratories and IITFs
Current List of HHS-Certified must meet in order to conduct drug and
use in agency decision-making; (5)
Laboratories and Instrumented Initial specimen validity tests on urine
works collaboratively with the National
Testing Facilities Which Meet Minimum specimens for federal agencies.
Mental Health and Substance Use Policy
Standards To Engage in Urine Drug To become certified, an applicant
Laboratory to provide support for
Testing for Federal Agencies laboratory or IITF must undergo three
SAMHSA evaluations; (6) oversees the
identification of a set of performance AGENCY: Substance Abuse and Mental rounds of performance testing plus an
indicators to monitor each SAMHSA Health Services Administration, HHS. on-site inspection. To maintain that
program in collaboration with program certification, a laboratory or IITF must
ACTION: Notice.
staff and the development of periodic participate in a quarterly performance
evaluation reports for use in agency SUMMARY: The Department of Health and testing program plus undergo periodic,
planning, program change, and Human Services (HHS) notifies federal on-site inspections.
reporting to departmental and external agencies of the laboratories and Laboratories and IITFs in the
organizations; (7) provides Instrumented Initial Testing Facilities applicant stage of certification are not to
collaboration, guidance, and systematic (IITF) currently certified to meet the be considered as meeting the minimum
feedback on SAMHSA’s programmatic standards of the Mandatory Guidelines requirements described in the HHS
investments to support the agency’s for Federal Workplace Drug Testing Mandatory Guidelines. A HHS-certified
policy and program decisions; (8) Programs (Mandatory Guidelines). laboratory or IITF must have its letter of
analyzes and disseminates evaluation A notice listing all currently HHS- certification from HHS/SAMHSA
related data and reports in support of certified laboratories and IITFs is (formerly: HHS/NIDA), which attests
Secretarial and Assistant Secretarial published in the Federal Register that it has met minimum standards.
during the first week of each month. If In accordance with the Mandatory
initiatives and develops evaluation and
any laboratory or IITF certification is Guidelines dated January 23, 2017 (82
performance related reports in response
suspended or revoked, the laboratory or FR 7920), the following HHS-certified
to internal and external requests; (9)
IITF will be omitted from subsequent laboratories and IITFs meet the
provides oversight of the agency’s
lists until such time as it is restored to minimum standards to conduct drug
quality improvement efforts, including
full certification under the Mandatory and specimen validity tests on urine
the collection, analysis, and reporting of
Guidelines. specimens:
performance measurement and quality
monitoring and improvement data; (10) If any laboratory or IITF has HHS-Certified Instrumented Initial
provides oversight and management of withdrawn from the HHS National Testing Facilities
SAMHSA’s Performance Accountability Laboratory Certification Program (NLCP)
during the past month, it will be listed Dynacare, 6628 50th Street NW,
and Reporting System (SPARS) which Edmonton, AB Canada T6B 2N7, 780–
serves as a mechanism for the collection at the end and will be omitted from the
monthly listing thereafter. 784–1190 (Formerly: Gamma-
of performance data from agency Dynacare Medical Laboratories).
grantees; (11) responds to agency and This notice is also available on the
departmental requests for performance internet at http://www.samhsa.gov/ HHS-Certified Laboratories
measurement data and information; and workplace.
ACM Medical Laboratory, Inc., 160
daltland on DSKBBV9HB2PROD with NOTICES

conducts a range of analytic and support FOR FURTHER INFORMATION CONTACT: Elmgrove Park, Rochester, NY 14624,
activities to promote the use of Giselle Hersh, Division of Workplace 844–486–9226.
performance data and information in the Programs, SAMHSA/CSAP, 5600 Alere Toxicology Services, 1111 Newton
monitoring and management of agency Fishers Lane, Room 16N03A, Rockville, St., Gretna, LA 70053, 504–361–8989/
programs and initiatives; and (12) Maryland 20857; 240–276–2600 (voice). 800–433–3823 (Formerly: Kroll
maintains the posting, on the internet, SUPPLEMENTARY INFORMATION: The Laboratory Specialists, Inc.,
of information on evidence-based Department of Health and Human Laboratory Specialists, Inc.).

VerDate Sep<11>2014 17:40 Jun 29, 2018 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\02JYN1.SGM 02JYN1

30948 Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices

Alere Toxicology Services, 450 2088, Testing for Veterans Affairs Upon finding a Canadian laboratory to
Southlake Blvd., Richmond, VA (VA) Employees Only. be qualified, HHS will recommend that
23236, 804–378–9130 (Formerly: National Toxicology Laboratories, Inc., DOT certify the laboratory (Federal
Kroll Laboratory Specialists, Inc., 1100 California Ave., Bakersfield, CA Register, July 16, 1996) as meeting the
Scientific Testing Laboratories, Inc.; 93304, 661–322–4250/800–350–3515. minimum standards of the Mandatory
Kroll Scientific Testing Laboratories, One Source Toxicology Laboratory, Inc., Guidelines published in the Federal
Inc.). 1213 Genoa-Red Bluff, Pasadena, TX Register on January 23, 2017 (82 FR
Baptist Medical Center—Toxicology 77504, 888–747–3774 (Formerly: 7920). After receiving DOT certification,
Laboratory, 11401 I–30, Little Rock, University of Texas Medical Branch, the laboratory will be included in the
AR 72209–7056, 501–202–2783 Clinical Chemistry Division; UTMB monthly list of HHS-certified
(Formerly: Forensic Toxicology Pathology-Toxicology Laboratory). laboratories and participate in the NLCP
Laboratory Baptist Medical Center). Pacific Toxicology Laboratories, 9348 certification maintenance program.
Clinical Reference Laboratory, Inc., 8433 DeSoto Ave., Chatsworth, CA 91311,
Quivira Road, Lenexa, KS 66215– 800–328–6942 (Formerly: Centinela Charles P. LoDico,
2802, 800–445–6917. Hospital Airport Toxicology Chemist.
DrugScan, Inc., 200 Precision Road, Laboratory). [FR Doc. 2018–14143 Filed 6–29–18; 8:45 am]
Suite 200, Horsham, PA 19044, 800– Pathology Associates Medical BILLING CODE 4160–20–P
235–4890. Laboratories, 110 West Cliff Dr.,
Dynacare*, 245 Pall Mall Street, Spokane, WA 99204, 509–755–8991/
London, ONT, Canada N6A 1P4, 519– 800–541–7891x7. DEPARTMENT OF HOMELAND
679–1630 (Formerly: Gamma- Phamatech, Inc., 15175 Innovation
SECURITY
Dynacare Medical Laboratories). Drive, San Diego, CA 92128, 888–
ElSohly Laboratories, Inc., 5 Industrial 635–5840. U.S. Citizenship and Immigration
Park Drive, Oxford, MS 38655, 662– Quest Diagnostics Incorporated, 1777 Services
236–2609. Montreal Circle, Tucker, GA 30084,
Laboratory Corporation of America 800–729–6432 (Formerly: SmithKline [OMB Control Number 1615–0100]
Holdings, 7207 N. Gessner Road, Beecham Clinical Laboratories;
SmithKline Bio-Science Laboratories). Agency Information Collection
Houston, TX 77040, 713–856–8288/
Quest Diagnostics Incorporated, 400 Activities; Revision of a Currently
800–800–2387.
Egypt Road, Norristown, PA 19403, Approved Collection: Request for the
Laboratory Corporation of America
610–631–4600/877–642–2216 Return of Original Documents;
Holdings, 69 First Ave., Raritan, NJ
(Formerly: SmithKline Beecham Correction
08869, 908–526–2400/800–437–4986
(Formerly: Roche Biomedical Clinical Laboratories; SmithKline Bio- AGENCY: U.S. Citizenship and
Laboratories, Inc.). Science Laboratories). Immigration Services, Department of
Laboratory Corporation of America Redwood Toxicology Laboratory, 3700 Homeland Security.
Holdings, 1904 TW Alexander Drive, Westwind Blvd., Santa Rosa, CA
95403, 800–255–2159. ACTION: 30-Day notice; correction.
Research Triangle Park, NC 27709,
919–572–6900/800–833–3984 STERLING Reference Laboratories, 2617
SUMMARY: The Department of Homeland
(Formerly: LabCorp Occupational East L Street, Tacoma, WA 98421,
Security (DHS), U.S. Citizenship and
Testing Services, Inc., CompuChem 800–442–0438.
Immigration Services (USCIS) will be
Laboratories, Inc.; CompuChem U.S. Army Forensic Toxicology Drug
submitting the following information
Laboratories, Inc., A Subsidiary of Testing Laboratory, 2490 Wilson St.,
collection request to the Office of
Roche Biomedical Laboratory; Roche Fort George G. Meade, MD 20755–
Management and Budget (OMB) for
CompuChem Laboratories, Inc., A 5235, 301–677–7085, Testing for
review and clearance in accordance
Member of the Roche Group). Department of Defense (DoD)
with the Paperwork Reduction Act of
Laboratory Corporation of America Employees Only.
1995. The purpose of this notice is to
Holdings, 1120 Main Street, * The Standards Council of Canada allow an additional 30 days for public
Southaven, MS 38671, 866–827–8042/ (SCC) voted to end its Laboratory comments. DHS, USCIS published a
800–233–6339 (Formerly: LabCorp Accreditation Program for Substance document in the Federal Register of
Occupational Testing Services, Inc.; Abuse (LAPSA) effective May 12, 1998. June 26, 2018, concerning request for
MedExpress/National Laboratory Laboratories certified through that comments on USCIS Form G–884. The
Center). program were accredited to conduct document contains incorrect
LabOne, Inc. d/b/a Quest Diagnostics, forensic urine drug testing as required identification of the Type of Information
10101 Renner Blvd., Lenexa, KS by U.S. Department of Transportation Request.
66219, 913–888–3927/800–873–8845 (DOT) regulations. As of that date, the
DATES: The purpose of this notice is to
(Formerly: Quest Diagnostics certification of those accredited
Canadian laboratories will continue allow an additional 30 days for public
Incorporated; LabOne, Inc.; Center for comments. Comments are encouraged
Laboratory Services, a Division of under DOT authority. The responsibility
for conducting quarterly performance and will be accepted until August 1,
LabOne, Inc.). 2018.
MedTox Laboratories, Inc., 402 W testing plus periodic on-site inspections
County Road D, St. Paul, MN 55112, of those LAPSA-accredited laboratories ADDRESSES: Written comments and/or
651–636–7466/800–832–3244. was transferred to the U.S. HHS, with suggestions regarding the item(s)
daltland on DSKBBV9HB2PROD with NOTICES

Legacy Laboratory Services—MetroLab, the HHS’ NLCP contractor continuing to contained in this notice, especially
1225 NE 2nd Ave., Portland, OR have an active role in the performance regarding the estimated public burden
97232, 503–413–5295/800–950–5295. testing and laboratory inspection and associated response time, must be
Minneapolis Veterans Affairs Medical processes. Other Canadian laboratories directed to the OMB USCIS Desk Officer
Center, Forensic Toxicology wishing to be considered for the NLCP via email at dhsdeskofficer@
Laboratory, 1 Veterans Drive, may apply directly to the NLCP omb.eop.gov. All submissions received
Minneapolis, MN 55417, 612–725– contractor just as U.S. laboratories do. must include the agency name and the

VerDate Sep<11>2014 17:40 Jun 29, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\02JYN1.SGM 02JYN1

Document Created: 2018-06-30 00:17:34
Document Modified: 2018-06-30 00:17:34

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice).
FR Citation		83 FR 30947

83 FR 30947 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICESSubstance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 127 (July 2, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration